HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast

por Bardia, Aditya, Viale, Giuseppe
Publicado 2023

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology

por Vidula, Neelima, Bardia, Aditya
Publicado 2017

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer

por Vidula, Neelima, Ellisen, Leif W., Bardia, Aditya
Publicado 2021

Precision medicine and personalized breast cancer: combination pertuzumab therapy

por Reynolds, Kerry, Sarangi, Sasmit, Bardia, Aditya, Dizon, Don S
Publicado 2014

Novel antibody–drug conjugates for triple negative breast cancer

por Nagayama, Aiko, Vidula, Neelima, Ellisen, Leif, Bardia, Aditya
Publicado 2020

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations

por Spring, Laura M., Zangardi, Mark L., Moy, Beverly, Bardia, Aditya
Publicado 2017

Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital

por Bardia, Aditya, Iafrate, John A., Sundaresan, Tilak, Younger, Jerry, Nardi, Valentina
Publicado 2016

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer

por Brett, Jamie O., Spring, Laura M., Bardia, Aditya, Wander, Seth A.
Publicado 2021

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging...

por Lloyd, Maxwell R., Wander, Seth A., Hamilton, Erika, Razavi, Pedram, Bardia, Aditya
Publicado 2022

Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan

por Bardia, Aditya, Harnden, Kathleen, Mauro, Lauren, Pennisi, Angela, Armitage, Melissa, Soliman, Hatem
Publicado 2022

Mechanisms of Resistance to Antibody–Drug Conjugates

por Abelman, Rachel Occhiogrosso, Wu, Bogang, Spring, Laura M., Ellisen, Leif W., Bardia, Aditya
Publicado 2023

Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer

por Vidula, Neelima, Niemierko, Andrzej, Hesler, Katherine, Ryan, Lianne, Moy, Beverly, Isakoff, Steven, Ellisen, Leif, Juric, Dejan, Bardia, Aditya
Publicado 2023

Spinal intradural extraosseous Ewing's sarcoma

por Mateen, Farrah J., Nassar, Aziza, Bardia, Aditya, Jatoi, Aminah, Haddock, Michael G., Buckner, Jan C., Lachance, Daniel H.
Publicado 2011

AKT1(low) quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer

por Kabraji, Sheheryar, Solé, Xavier, Huang, Ying, Bango, Clyde, Bowden, Michaela, Bardia, Aditya, Sgroi, Dennis, Loda, Massimo, Ramaswamy, Sridhar
Publicado 2017

Pharmacodynamic study of Disulfiram in Men with Non-metastatic Recurrent Prostate Cancer

por Schweizer, Michael T., Lin, Jianqing, Blackford, Amanda, Bardia, Aditya, King, Serina, Armstrong, Andrew J., Rudek, Michelle A., Yegnasubramanian, Srinivasan, Carducci, Michael A.
Publicado 2013

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

por McCarthy, Anne Marie, Kumar, Nitya Pradeep, He, Wei, Regan, Susan, Welch, Michaela, Moy, Beverly, Iafrate, A. John, Chan, Andrew T., Bardia, Aditya, Armstrong, Katrina
Publicado 2020

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

por Spring, Laura M., Specht, Michelle C., Jimenez, Rachel B., Isakoff, Steven J., Wang, Gary X., Ly, Amy, Shin, Jennifer A., Bardia, Aditya, Moy, Beverly
Publicado 2020

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer

por McLaughlin, Shannon, Nakajima, Erika, Bar, Yael, Hutchinson, Jennifer A., Shin, Jennifer, Moy, Beverly, Isakoff, Steven J., Bardia, Aditya, Kuter, Irene, Spring, Laura M.
Publicado 2023

Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53

por Scarpetti, Lauren, Oturkar, Chetan C, Juric, Dejan, Shellock, Maria, Malvarosa, Giuliana, Post, Kathryn, Isakoff, Steven, Wang, Nancy, Nahed, Brian, Oh, Kevin, Das, Gokul M, Bardia, Aditya
Publicado 2023

AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer

por Bardia, Aditya, Cortes, Javier, Hurvitz, Sara A., Delaloge, Suzette, Iwata, Hiroji, Shao, Zhi-Ming, Kanagavel, Dheepak, Cohen, Patrick, Liu, Qianying, Cartot-Cotton, Sylvaine, Pelekanou, Vasiliki, O’Shaughnessy, Joyce
Publicado 2022